Chemoinformaics analysis of 3-methyl-6- hydroxy-heneicos-3-enyl Acetate
| Molecular Weight | 382.629 | nRot | 19 |
| Heavy Atom Molecular Weight | 336.261 | nRig | 2 |
| Exact Molecular Weight | 382.345 | nRing | 0 |
| Solubility: LogS | -6.303 | nHRing | 0 |
| Solubility: LogP | 8.425 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 73.1585 |
| nHD | 1 | BPOL | 48.7515 |
| QED | 0.147 |
| Synth | 2.898 |
| Natural Product Likeliness | 1.142 |
| NR-PPAR-gamma | 0.173 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.676 |
| HIA | 0.005 |
| CACO-2 | -4.777 |
| MDCK | 0.0000208 |
| BBB | 0.075 |
| PPB | 0.98292 |
| VDSS | 1.633 |
| FU | 0.0237424 |
| CYP1A2-inh | 0.259 |
| CYP1A2-sub | 0.16 |
| CYP2c19-inh | 0.304 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.156 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.049 |
| CYP2d6-sub | 0.027 |
| CYP3a4-inh | 0.321 |
| CYP3a4-sub | 0.054 |
| CL | 4.793 |
| T12 | 0.128 |
| hERG | 0.082 |
| Ames | 0.004 |
| ROA | 0.003 |
| SkinSen | 0.968 |
| Carcinogencity | 0.062 |
| EI | 0.962 |
| Respiratory | 0.214 |
| NR-Aromatase | 0.285 |
| Antiviral | Yes |
| Prediction | 0.635467 |